Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Publish
Dashboard
Subscribe to $XRTX
XORTX Therapeutics Inc.
Subscribe to $XRTX
$XRTX
Biotechnology: Pharmaceutical Preparations
Health Care
IPO Year:
Exchange: NASDAQ
Recent Analyst Ratings for XORTX Therapeutics Inc.
Date
Price Target
Rating
Analyst
12/9/2021
$11.00
Buy
Alliance Global Partners
See more ratings
